These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 25406123)
1. European ombudsman questions European Medicines Agency over AbbVie redactions. Watson R BMJ; 2014 Nov; 349():g6904. PubMed ID: 25406123 [No Abstract] [Full Text] [Related]
2. European Medicines Agency pledges to publish clinical reports. Watson R BMJ; 2014 Oct; 349():g6086. PubMed ID: 25294699 [No Abstract] [Full Text] [Related]
3. AbbVie considers harms to be commercially confidential information: sign a petition. Gøtzsche PC BMJ; 2013 Dec; 347():f7569. PubMed ID: 24366821 [No Abstract] [Full Text] [Related]
4. The European Medicines Agency's plans for sharing data from clinical trials. Groves T; Godlee F BMJ; 2013 May; 346():f2961. PubMed ID: 23657192 [No Abstract] [Full Text] [Related]
5. Drug company drops case after EMA agrees to redactions in some documents to be published. Dyer C BMJ; 2014 Apr; 348():g2632. PubMed ID: 24709373 [No Abstract] [Full Text] [Related]
6. How can we regulate medicines better? Garattini S; Bertele' V BMJ; 2007 Oct; 335(7624):803-5. PubMed ID: 17947785 [TBL] [Abstract][Full Text] [Related]
7. EU directive on clinical trials penalizes small sponsors. Meldolesi A Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186 [No Abstract] [Full Text] [Related]
8. The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation. Pignatti F; Gravanis I; Herold R; Vamvakas S; Jonsson B; Marty M Clin Cancer Res; 2011 Aug; 17(16):5220-5. PubMed ID: 21844037 [TBL] [Abstract][Full Text] [Related]
9. Drug regulation 2056. Bezold C; Peck J Food Drug Law J; 2005; 60(2):127-36. PubMed ID: 16097091 [No Abstract] [Full Text] [Related]
10. Lessons from Eprex for biogeneric firms. Louët S Nat Biotechnol; 2003 Sep; 21(9):956-7. PubMed ID: 12949539 [No Abstract] [Full Text] [Related]
11. Informed by the European Union experience: what the United States can anticipate and learn from the European Union's regulatory approach to biosimilars. Gitter DM Seton Hall Law Rev; 2011; 41(2):559-92. PubMed ID: 21739759 [No Abstract] [Full Text] [Related]
12. The European Medicines Agency: a public health European agency? Mahalatchimy A; Rial-Sebbag E; De Grove-Valdeyron N; Tournay V; Cambon-Thomsen A; Duguet AM; Taboulet F Med Law; 2012 Mar; 31(1):25-42. PubMed ID: 22908736 [TBL] [Abstract][Full Text] [Related]
13. European Ombudsman ramps up action against European Medicines Agency over data transparency plans. Torjesen I BMJ; 2014 Jun; 348():g3733. PubMed ID: 24904032 [No Abstract] [Full Text] [Related]
14. Medicines agencies too often under the influence of drug companies. Prescrire Int; 2011 Apr; 20(115):108. PubMed ID: 21648219 [No Abstract] [Full Text] [Related]
15. Provision of information on regulatory authorities' websites. Vitry A; Lexchin J; Sasich L; Dupin-Spriet T; Reed T; Bertele V; Garattini S; Toop L; Hurley E Intern Med J; 2008 Jul; 38(7):559-67. PubMed ID: 18336542 [TBL] [Abstract][Full Text] [Related]
18. FDA tightens its grip on drug regulation. Coombes R BMJ; 2007 Feb; 334(7588):290-1. PubMed ID: 17289729 [TBL] [Abstract][Full Text] [Related]
19. Out in the open. Nat Biotechnol; 2005 Feb; 23(2):153. PubMed ID: 15696130 [No Abstract] [Full Text] [Related]
20. Glaxo agrees to post results of drug trials on web site. Harris G N Y Times Web; 2004 Aug; ():C4. PubMed ID: 15540364 [No Abstract] [Full Text] [Related] [Next] [New Search]